Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a generic error page instead of the study record details. This indicates the resource is currently unavailable.SummaryDifference21%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a back-end or content-management update. This update does not modify the trial details or other substantive content displayed on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 to reflect a new page version.SummaryDifference0.0%

- Check44 days agoChange DetectedThe revision tag was updated: 'Revision: v3.6.2' was added and the previous 'Revision: v3.6.0' tag was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded user guidance sections and a recruitment-status notice to improve navigation and participation clarity. Updated formatting of the Intervention/Treatment heading and bumped the site revision from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check65 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5. This indicates a new release/version of the software or documentation.SummaryDifference0.0%

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.